Valérie Bardet

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

Sophie Park, Sophie Grabar, Charikleia Kelaïdi et al. · Blood · 2007 · 330 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Lise Willems, Nathalie Jacque, Arnaud Jacquel et al. · Blood · 2013 · 286 citations

Medicine, Oncology, Pharmacology +8

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

Dorothée Selimoglu‐Buet, Orianne Wagner‐Ballon, Véronique Saada et al. · Blood · 2015 · 259 citations

Medicine, Hematology, Immunology +16

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet et al. · Blood · 2007 · 252 citations

Medicine, Oncology, Pharmacology +16

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

Alexa S. Green, Nicolas Chapuis, Thiago Trovati Maciel et al. · Blood · 2010 · 197 citations · Full text

Life Sciences, Molecular Biology, Oncology +16